Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: He, Qinga; b; * | Zeng, Qiangchenga; b | Shao, Yiboa | Zhou, Haixiaa | Li, Tianjiaoa | Song, Fanga | Liu, Weia
Affiliations: [a] Shandong Key Laboratory in University of Functional Bioresource Utilization, College of Life Science, Dezhou University, Dezhou, Shandong, China | [b] Shandong Provincial Key Laboratory of Biophysics, Dezhou University, Dezhou, Shandong, China
Correspondence: [*] Corresponding author: Qing He, Shandong Key Laboratory in University of Functional Bioresource Utilization, College of Life Science, Dezhou University, No. 566, University Road West, Dezhou, Shangdong 253023, China. E-mail: heqing19831016@sina.com.
Abstract: OBJECTIVES: The purpose of this study was to isolate the secondary metabolites of endophytic fungi from Ginkgo biloba (SMEFGB) and investigate their anti-cervical cancer activity. METHODS: SMEFGB were cultured. The secondary metabolites of endophytic fungi was extracted, purified and identified. The effects of secondary metabolites on proliferation, apoptosis and migration of human cervical cancer HeLa cells were determined. In addition, the effects of SMEFGB on growth of Hela implanted tumor in mice were investigated. RESULTS: In 9 stains of endophytic fungi successfully isolated from the leaves of Ginkgo biloba, the stain J-1, J-2 and J-3 could produce podophyllotoxin. These 3 stains were identified by molecular biology. The secondary metabolites of stain J-1, J-2 and J-3 markedly inhibited the proliferation of HeLa cells, promoted their apoptosis and blocked their migration. In addition, the secondary metabolites of stain J-1, J-2 and J-3 significantly attenuated the growth of HeLa implanted tumor in mice. CONCLUSIONS: Our results indicated that SMEFGB had obvious anti-cervical cancer activity in vitro and in vivo.
Keywords: Secondary metabolites, endophytic fungi, Ginkgo biloba, cervical cancer, anti-cervical cancer activity
DOI: 10.3233/CBM-190462
Journal: Cancer Biomarkers, vol. 28, no. 3, pp. 371-379, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl